Acrospire Investment Management LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 182 filers reported holding HAEMONETICS CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2017$51,000
-16.4%
1,300
-13.3%
0.05%
-4.0%
Q1 2017$61,000
-68.4%
1,500
-68.8%
0.05%
-36.7%
Q4 2016$193,000
+56.9%
4,800
+41.2%
0.08%
-3.7%
Q3 2016$123,000
+192.9%
3,400
+183.3%
0.08%
+182.8%
Q1 2016$42,0001,2000.03%
Other shareholders
HAEMONETICS CORP shareholders Q1 2017
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders